Target intelligence / Profile preview

UDP-galactose:ceramide galactosyltransferase (UGT8)

Target
UGT8
Molecular classification
Enzyme, Glycosyltransferase
01

Overview

UDP-galactose:ceramide galactosyltransferase (UGT8) is a class I integral membrane enzyme located in the endoplasmic reticulum. It catalyzes the transfer of galactose from UDP-galactose to ceramide, producing galactosylceramide—the major sphingolipid component of myelin in the central and peripheral nervous systems. This enzymatic activity is essential for proper myelination of neurons. UGT8 is also found in some epithelial tissues and has roles in lipid and protein sorting. Deficits or misregulation of this enzyme are implicated in neurological disorders (such as Krabbe disease) and certain cancers (for example, as a molecular marker for aggressive breast cancer)

Other names
Ceramide galactosyltransferaseN-acylsphingosine galactosyltransferaseCGTUDP galactose-N-acylsphingosine galactosyltransferaseuridine diphosphogalactose-acylsphingosine galactosyltransferase2-hydroxyacylsphingosine 1-β-galactosyltransferase
02

Mechanism of action

Inhibition of UGT8 blocks galactocerebroside synthesis

03

Biological functions

Sphingolipid biosynthesisMyelin formationLipid and protein sorting
04

Disease associations

Neurodegenerative diseaseCancerOther
05

Safety considerations

Potential neurological toxicity
06

Biomarkers

UGT8/CGT protein levels

Beyond the preview

Go deeper on UDP-galactose:ceramide galactosyltransferase (UGT8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UDP-galactose:ceramide galactosyltransferase (UGT8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call